Progress in Cardiovascular Diseases
Volume 51, Issue 1 , Pages 44-57 , July 2008

Sudden Cardiac Death in Athletes

  • Mark S. Link

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Mark S. Link, MD, Tufts New England Medical Center, NEMC Box #197, 750 Washington Street, Boston, MA 02111.
    • ,
  • N.A. Mark Estes III

References 

  1. Maron BJ, Douglas PS, Graham TP, et al. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol. 2005;45:1322–1326
  2. Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324:295–301
  3. Pelliccia A, Culasso F, Di Paolo FM, et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med. 1999;130:23–31
  4. Wharton J. “Athlete's heart”: the medical debate over athleticism, 1870-1920. In:  Berryman JW,  Park RJ editor. Sport and exercise science, essays in the history of sports medicine. Urbana (Ill): University of Illinois Press; 1992;
  5. Rost R. The athlete's heart. Historical perspectives-solved and unsolved problems. Cardiol Clin. 1997;15:493–512
  6. Abernethy WB, Choo JK, Hutter AM. Echocardiographic characteristics of professional football players. J Am Coll Cardiol. 2003;41:280–284
  7. Scharhag J, Schneider G, Urhausen A, et al. Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol. 2002;40:1856–1863
  8. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance. Heart. 2005;91:1380–1382
  9. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006;114:1633–1644
  10. Pelliccia A, Maron BJ, Culasso F, et al. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. JAMA. 1996;276:211–215
  11. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation. 2000;102:278–284
  12. Serra-Grima R, Estorch M, Carrio I, et al. Marked ventricular repolarization abnormalities in highly trained athletes' electrocardiograms: Clinical and prognostic implications. J Am Coll Cardiol. 2000;36:1310–1316
  13. Chapman J. Profound sinus bradycardia in the athletic heart syndrome. J Sports Med Phys Fitness. 1981;22:294–298
  14. Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002;40:446–452
  15. Talan DA, Bauernfeind RA, Ashley WW, et al. Twenty-four hour continuous ECG recordings in long-distance runners. Chest. 1982;82:19–24
  16. Zehender M, Meinertz T, Keul J, et al. ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J. 1990;119:1378–1391
  17. Douglas PS, O'Toole ML, Hiller WD, et al. Electrocardiographic diagnosis of exercise-induced left ventricular hypertrophy. Am Heart J. 1988;116:784–790
  18. Balady GJ, Cadigan JB, Ryan TJ. Electrocardiogram of the athlete: an analysis of 289 professional football players. Am J Cardiol. 1984;53:1339–1343
  19. Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med. 1998;129:379–386
  20. Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol. 2003;42:1959–1963
  21. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785–789
  22. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364–369
  23. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349:1064–1075
  24. Puranik R, Chow CK, Duflou JA, et al. Sudden death in the young. Heart Rhythm. 2005;2:1277–1282
  25. Ellsworth EG, Ackerman MJ. The changing face of sudden cardiac death in the young. Heart Rhythm. 2005;2:1283–1285
  26. Maron BJ, Ackerman MJ, Nishimura RA, et al. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. J Am Coll Cardiol. 2005;45:1340–1345
  27. Frenneaux MP. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart. 2004;90:570–575
  28. Maron BJ, Moller JH, Seidman CE, et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long QT syndrome, and Marfan syndrome. Circulation. 1998;98:1460–1471
  29. Elliott PM, Blanes JRG, Mahan NG, et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;357:420–424
  30. Maron BJ, Spirito P, Shen WK, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405–412
  31. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–3091
  32. Hulot JS, Jouven X, Empana JP, et al. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2004;110:1879–1884
  33. Roguin A, Bomma CS, Nasir K, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2004;43:1843–1852
  34. Wichter T, Paul M, Wollmann C, et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation. 2004;109:1503–1508
  35. Zipes DP, Ackerman MJ, Estes NAM, et al. Task Force 7: Arrhythmias. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. J Am Coll Cardiol. 2005;45:43–52
  36. Corrado D, Basso C, Poletti A, et al. Sudden death in the young. Is acute coronary thrombosis the major precipitating factor?. Circulation. 1994;90:2315–2323
  37. Thompson PD, Balady GJ, Chaitman BR, et al. Task Force 6: coronary artery disease. J Am Coll Cardiol. 2005;45:1348–1353
  38. Basso C, Corrado D, Thiene G. Congenital coronary artery anomalies as an important cause of sudden death in the young. Cardiol Rev. 2001;9:312–317
  39. Graham TP, Driscoll DJ, Gersony WM, et al. Task Force 2: congenital heart disease. J Am Coll Cardiol. 2005;45:1326–1333
  40. Wellens HJ. Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram. Circulation. 2005;112:2201–2207[discussion 16]
  41. Pappone C, Santinelli V. Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome. Circulation. 2005;112:2207–2215[discussion 16]
  42. Chugh SS, Senashova O, Watts A, et al. Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol. 2004;43:1625–1629
  43. Tester DJ, Spoon DB, Valdivia HH, et al. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc. 2004;79:1380–1384
  44. Kass RS, Moss AJ. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest. 2003;112:810–815
  45. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89–95
  46. Tester DJ, Will ML, Haglund CM, et al. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol. 2006;47:764–768
  47. Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation. 2006;113:1385–1392
  48. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101:616–623
  49. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111:659–670
  50. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation. 2002;105:1342–1347
  51. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation. 2003;108:3092–3096
  52. Eckardt L, Probst V, Smits JP, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation. 2005;111:257–263
  53. Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome: a familial cause of sudden death. Circulation. 2003;108:965–970
  54. Maron BJ, Doerer JJ, Haas TS, et al. Historical observation on commotio cordis. Heart Rhythm. 2006;3:605–606
  55. Maron BJ, Gohman TE, Kyle SB, et al. Clinical profile and spectrum of commotio cordis. JAMA. 2002;287:1142–1146
  56. Nesbitt AD, Cooper PJ, Kohl P. Rediscovering commotio cordis. Lancet. 2001;357:1195–1197
  57. Maron BJ, Poliac LC, Kaplan JA, et al. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med. 1995;333:337–342
  58. Maron BJ, Wentzel DC, Zenovich AG, et al. Death in a young athlete due to commotio cordis despite prompt external defibrillation. Heart Rhythm. 2005;2:991–993
  59. Drezner JA, Rogers KJ. Sudden cardiac arrest in intercollegiate athletes: detailed analysis and outcomes of resuscitation in nine cases. Heart Rhythm. 2006;3:755–759
  60. Link MS. Resuscitation in athletes: a sobering tale. Heart Rhythm. 2006;3:760–761
  61. Link MS, Wang PJ, Pandian NG, et al. An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis). N Engl J Med. 1998;338:1805–1811
  62. Link MS, Maron BJ, VanderBrink BA, et al. Impact directly over the cardiac silhouette is necessary to produce ventricular fibrillation in an experimental model of commotio cordis. J Am Coll Cardiol. 2001;37:649–654
  63. Link MS, Estes NA. Mechanically induced ventricular fibrillation (commotio cordis). Heart Rhythm. 2007;4:529–532
  64. Link MS, Maron BJ, Wang PJ, et al. Upper and lower limits of vulnerability to sudden arrhythmic death with chest-wall impact (commotio cordis). J Am Coll Cardiol. 2003;41:99–104
  65. Link MS, Maron BJ, Wang PJ, et al. Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs. Pediatrics. 2002;109:873–877
  66. Bode F, Franz MR, Wilke I, et al. Ventricular fibrillation induced by stretch pulse: implications for sudden death due to commotio cordis. J Cardiovasc Electrophysiol. 2006;17:1011–1017
  67. Link MS. Mechanically induced sudden death in chest wall impact. Prog Biophys Mol Biol. 2003;82:175–186
  68. Kohl P, Nesbitt AD, Cooper PJ, et al. Sudden cardiac death by commotio cordis: role of mechanico-electrical feedback. Cardiovasc Res. 2001;50:280–289
  69. Kohl P, Ravens U. Cardiac mechano-electric feedback: past, present, and prospect. Prog Biophys Mol Biol. 2003;82:3–9
  70. Link MS, Wang PJ, VanderBrink BA, et al. Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (commotio cordis). Circulation. 1999;100:413–418
  71. Van Wagoner DR. Mechanosensitive gating of atrial ATP-sensitive potassium channels. Circ Res. 1993;72:973–983
  72. Weinstock J, Maron BJ, Song C, et al. Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis. Pediatrics. 2006;117:e656–e662
  73. Maron BJ, Estes NA, Link MS. Task Force 11: Commotio cordis: 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. J Am Coll Cardiol. 2005;45:1371–1373
  74. Kramer MR, Drori Y, Lev B. Sudden death in young soldiers: high incidence of syncope prior to death. Chest. 1988;93:345–347
  75. Link MS, Wang PJ, Estes NAM. Cardiac arrhythmias and electrophysiologic observations in the athlete. In:  Richard A,  Williams M editor. The athlete and heart disease. Philadelphia: Lippincott Williams & Wilkins; 1998;p. 197–216
  76. Savage D, Seides S, Clark C, et al. Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation. 1978;58:402–408
  77. Wigle ED, Rakowski H, Kimball BP, et al. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995;92:1680–1692
  78. Vincent GM, Timothy KW, Leppert M, et al. The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med. 1992;327:846–852
  79. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593–1601

PII: S0033-0620(07)00100-4

doi: 10.1016/j.pcad.2007.10.002

Progress in Cardiovascular Diseases
Volume 51, Issue 1 , Pages 44-57 , July 2008

Article Tools

* Image Usage & Resolution